The novel therapy of this peptide represents a significant breakthrough in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide575761.aboutyoublog.com/54674472/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment